Preliminary phase I results of G3139 (bcl-2 antisense oligonucleotide) therapy in combination with docetaxel in hormone-refractory prostate cancer
- 31 August 2001
- journal article
- Published by Elsevier in Seminars in Oncology
- Vol. 28, 67-70
- https://doi.org/10.1016/s0093-7754(01)90158-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: